• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

DDR2 Gene Record

  • Summary
  • Interactions
  • Claims
  • DDR2 4921 Druggable GenomeClinically Actionable

    Alternate Names:

    4921
    DISCOIDIN DOMAIN RECEPTOR TYROSINE KINASE 2
    DDR2
    MIG20a
    NTRKR3
    TKT
    TYRO10
    191311
    2731
    ENSG00000162733
    OTTHUMG00000034423
    Q16832
    DDR2_HUMAN
    Discoidin domain receptor 2
    Tyrosine-protein kinase TYRO10
    Receptor protein-tyrosine kinase TKT
    Neurotrophic tyrosine kinase, receptor-related 3
    Discoidin domain-containing receptor tyrosine kinase 2
    CD167 antigen-like family member B
    Discoidin domain-containing receptor 2
    CD_antigen=CD167b
    DISCOIDIN DOMAIN RECEPTOR 2 PRECURSOR (EC 2.7.1.112) (RECEPTOR PROTEIN-TYROSINE KINASE TKT) (TYROSINE-PROTEIN KINASE TYRO 10) (NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 3). [SOURCE:UNIPROT/SWISSPROT;ACC:Q16832]
    51
    T11764
    WRCN

    Gene Info:

    Interpro Type Domain
    Human Readable Name KINASE
    Interpro Acc IPR001245
    Interpro Short Name Ser-Thr/Tyr_kinase_cat_dom
    Uniprot Evidence 1: Evidence at protein level
    Human Readable Name DRUGGABLE GENOME
    Uniprot Status Swiss-Prot
    Interpro Name Serine-threonine/tyrosine-protein kinase catalytic domain
    Gene Biotype PROTEIN_CODING
    (13 More Sources)

    Gene Categories: Category Details

    KINASE
    TYROSINE KINASE
    DRUGGABLE GENOME
    CLINICALLY ACTIONABLE
    TRANSCRIPTION FACTOR

    Publications:

    Pitini et al., 2013, Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia., Lung Cancer
    Day et al., 2008, Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib., Eur. J. Pharmacol.
    Hammerman et al., 2011, Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer., Cancer Discov
    Murray CW et al., 2015, Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors., ACS Med Chem Lett
  • NILOTINIB   DDR2

    Interaction Score: 2.25

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:

    PMIDs:
    26191369


    Sources:
    DTC

  • SARACATINIB   DDR2

    Interaction Score: 2.06

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    26191369


    Sources:
    DTC

  • ERLOTINIB   DDR2

    Interaction Score: 1.29

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Clinical Status case report
    Pathway activation
    Variant Effect gain-of-function

    PMIDs:
    22328973 23932362 18938156


    Sources:
    DoCM CIViC

  • DASATINIB   DDR2

    Interaction Score: 1.06

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Clinical Status preclinical
    Pathway activation
    Variant Effect gain-of-function

    PMIDs:
    23932362 18938156 22328973


    Sources:
    DoCM CIViC MyCancerGenomeClinicalTrial

  • REGORAFENIB   DDR2

    Interaction Score: 0.88

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction Discoidin domain-containing receptor 2 inhibitor
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions MyCancerGenomeClinicalTrial

  • Ensembl: ENSG00000162733

    • Version: 101_38

    Alternate Names:
    DDR2 Ensembl Gene Name

    Gene Info:
    Gene Biotype PROTEIN_CODING

    Publications:

  • HopkinsGroom: Q16832

    • Version: 11-September-2012

    Alternate Names:
    DDR2 Uniprot Gene Name
    DISCOIDIN DOMAIN-CONTAINING RECEPTOR 2 Uniprot Protein Name
    DDR2_HUMAN Uniprot Id

    Gene Info:
    Interpro Type Domain
    Human Readable Name KINASE
    Interpro Acc IPR001245

    Gene Categories:
    KINASE, DRUGGABLE GENOME

    Publications:

  • RussLampel: ENSG00000162733

    • Version: 26-July-2011

    Alternate Names:
    DDR2 Display Id
    DISCOIDIN DOMAIN RECEPTOR 2 PRECURSOR (EC 2.7.1.112) (RECEPTOR PROTEIN-TYROSINE KINASE TKT) (TYROSINE-PROTEIN KINASE TYRO 10) (NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED 3). [SOURCE:UNIPROT/SWISSPROT;ACC:Q16832] Description
    ENSG00000162733 Ensembl Gene Id

    Gene Info:
    Human Readable Name DRUGGABLE GENOME

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • CIViC: DDR2

    • Version: 14-September-2020

    Alternate Names:
    4921 Entrez Gene ID
    51 CIViC Gene ID

    Gene Info:

    Publications:
    Hammerman et al., 2011, Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer., Cancer Discov

  • DoCM: DDR2

    • Version: 27-September-2017

    Alternate Names:

    Gene Info:

    Publications:
    Hammerman et al., 2011, Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer., Cancer Discov
    Pitini et al., 2013, Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia., Lung Cancer
    Day et al., 2008, Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib., Eur. J. Pharmacol.

  • DTC: DDR2

    • Version: 02-September-2020

    Alternate Names:

    Gene Info:

    Publications:
    Murray CW et al., 2015, Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors., ACS Med Chem Lett

  • HingoraniCasas: ENSG00000162733

    • Version: 31-May-2017

    Alternate Names:
    ENSG00000162733 Gene Symbol
    DDR2 Ensembl Id

    Gene Info:

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • ChemblInteractions: NTRKR3

    • Version: chembl_23

    Alternate Names:
    TKT GENE_SYMBOL
    TYRO10 GENE_SYMBOL
    DDR2 GENE_SYMBOL

    Gene Info:

    Publications:

  • Tempus: DDR2

    • Version: 11-November-2018

    Alternate Names:
    DDR2 Gene Symbol

    Gene Info:

    Gene Categories:
    CLINICALLY ACTIONABLE

    Publications:

  • dGene: DDR2

    • Version: 27-Jun-2013

    Alternate Names:
    4921 Gene ID
    MIG20a dGene Synonym
    NTRKR3 dGene Synonym

    Gene Info:

    Gene Categories:
    KINASE, TYROSINE KINASE

    Publications:

  • TTD: Discoidin domain-containing receptor 2

    • Version: 2020.06.01

    Alternate Names:
    DDR2 TTD Gene Abbreviation
    T11764 TTD Target ID

    Gene Info:

    Publications:

  • Pharos: DDR2

    • Version: 01-February-2022

    Alternate Names:
    Discoidin domain-containing receptor 2 Gene Name
    Q16832 UniProt ID

    Gene Info:

    Gene Categories:
    KINASE, TRANSCRIPTION FACTOR

    Publications:

  • MyCancerGenomeClinicalTrial: DDR2

    • Version: 30-February-2014

    Alternate Names:

    Gene Info:

    Publications:

  • MskImpact: DDR2

    • Version: May-2015

    Alternate Names:

    Gene Info:

    Gene Categories:
    CLINICALLY ACTIONABLE

    Publications:

  • FoundationOneGenes: DDR2

    • Version: 03-September-2020

    Alternate Names:

    Gene Info:

    Gene Categories:
    CLINICALLY ACTIONABLE

    Publications:

  • CarisMolecularIntelligence: DDR2

    • Version: 04-September-2020

    Alternate Names:

    Gene Info:

    Gene Categories:
    CLINICALLY ACTIONABLE

    Publications:

  • Oncomine: DDR2

    • Version: v3

    Alternate Names:

    Gene Info:

    Gene Categories:
    CLINICALLY ACTIONABLE

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21